Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH – Get Free Report) was up 3.8% during trading on Friday . The stock traded as high as $0.44 and last traded at $0.42. Approximately 130,742 shares were traded during trading, a decline of 71% from the average daily volume of 455,928 shares. The stock had previously closed at $0.41.
Shuttle Pharmaceuticals Stock Performance
The stock has a 50 day moving average of $0.66 and a two-hundred day moving average of $0.97. The stock has a market cap of $2.07 million, a PE ratio of -0.10 and a beta of -1.63.
Shuttle Pharmaceuticals Company Profile
Shuttle Pharmaceuticals Holdings, Inc, a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers .
Recommended Stories
- Five stocks we like better than Shuttle Pharmaceuticals
- How to trade penny stocks: A step-by-step guide
- FedEx Delivers Another Crushing Blow to Its Stock Price
- Comparing and Trading High PE Ratio Stocks
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- What Do S&P 500 Stocks Tell Investors About the Market?
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for Shuttle Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shuttle Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
